Navigation Links
Genomic Health Presents Results From First Clinical Decision Making Study of Oncotype DX® Colon Cancer at the 2012 Gastrointestinal Cancers Symposium
Date:1/20/2012

l stages of breast and colon cancers.  The company is based in Redwood City, California with European headquarters in Geneva, Switzerland.  For more information, please visit www.genomichealth.com.  To learn more about Oncotype DX tests, visit: www.oncotypedx.com and www.MyBreastCancerTreatment.org

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the ability of the test to optimize cancer treatment; the ability of the recurrence score  to impact  treatment decisions in a clinical setting;  the ability of the company to establish further coverage and reimbursement for its colon cancer test; the potential of the test to transform care for  colon cancer patients while saving the healthcare system money; the applicability of study results to clinical practice  and timing and results of future studies. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: the results of clinical studies; the applicability of clinical study results to actual outcomes; risks associated with competition and commercialization of  the test;  the risks and uncertainties associated with establishment of coverage and reimbursement;  additional  regulation of the company's tests; and the other risks set forth in the company's filings with the Securities and Exchange Commission, including the risks set forth in the company's Quarterly  Report  on Form 10-Q  for the period ended September  30, 2011. These forward-look
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
2. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
3. Genomic Technologies: Market Insights for Life Science Suppliers
4. SwitchGear Genomics and New England Biolabs Develop New Multiplex Reporter Assay System
5. Synthetic Genomics Inc. and Plenus, S.A. de C.V. Form New Sustainable Agriculture Company, Agradis, Inc. to Develop and Commercialize Products Using Genomic Technologies
6. New England Biolabs and Rubicon Genomics Enter into Distribution Agreement for Single Cell Amplification Products
7. Center for Proteomics at the Translational Genomics Research Institute (TGen) Selected as Waters Center of Innovation
8. Transgenomic Reports Second Quarter Financial Results
9. ACMG Announces New Online Live Learning Center: Will Bring Genetics and Genomics Education to Varied Health Professionals
10. Quest Diagnostics and Genomic Vision Form Strategic Collaboration to Develop Genome-based Laboratory Tests
11. Clinical Genomics Extends Strategic Alliance for Colorectal Cancer Testing Development with Quest Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015   PureTech , a ... and commercializing disruptive products and technologies in the healthcare ... , former CEO and Member of the Board of ... "It,s has been a pleasure to know ... that we will be working together more closely now," ...
(Date:2/26/2015)... , Feb. 26, 2015 /PRNewswire/ - SQI Diagnostics ... a life sciences company that develops and commercializes proprietary ... its financial and operational results for the fiscal first ... press release are in Canadian dollars (CAD), unless otherwise ... continued to win new business from our existing customers ...
(Date:2/26/2015)... 26, 2015 DuPont Executive Vice President ... key research advancements and product launches across the Agriculture ... America Merrill Lynch 2015 Global Agriculture Conference. ... grain supplies the last two years, long-term demand for ... of the last decade, when demand for corn and ...
(Date:2/26/2015)... The healthcare landscape is rapidly and radically changing. ... will host its 20 th Anniversary Medical Technologies ... to 10, at the Hilton San Diego Resort and Spa ... This event is a platform for global medical devices, diagnostics, ... and how to succeed in an uncertain future. ...
Breaking Biology Technology:Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5Embrace the Future of Medical Technologies with Frost & Sullivan 2Embrace the Future of Medical Technologies with Frost & Sullivan 3
... Sept. 17 MannKind Corporation,(Nasdaq: MNKD ) today ... and Drug Administration to use AFRESA as the trade ... was unveiled today by Alfred Mann,Chairman and Chief Executive ... Conn., location that marked the completion and,dedication of a ...
... Professor And Former Chair Of Psychology Department At Harvard University,Joins ... Leading ... Neurological Testing Company, BERKELEY, Calif., Sept. 17 ... neurological testing for marketing,research, announced that professor Stephen Kosslyn, Ph.D. ...
... based upon Gov. Deval ... Life Sciences Initiative -, LEXINGTON, Mass., Sept. ... Dedication of its new HQ/manufacturing facility, -- WHEN: ... -- WHERE: 44 Hartwell Avenue, Lexington, Mass., RainDance Technologies, ...
Cached Biology Technology:MannKind Unveils Proposed Trade Name at Dedication of Danbury Manufacturing Facility 2MannKind Unveils Proposed Trade Name at Dedication of Danbury Manufacturing Facility 3Neurofocus Appoints Stephen Kosslyn to Its Advisory Board 2RainDance Technologies to Dedicate New Headquarters, Manufacturing Facility in Lexington 2
(Date:1/22/2015)...  A man-made form of insulin delivered by nasal spray ... adults with mild cognitive impairment and Alzheimer,s disease dementia, ... Wake Forest Baptist Medical Center. The study,s ... impairment (MCI) or mild to moderate Alzheimer,s dementia (AD). ...
(Date:1/22/2015)... YORK , Jan. 21, 2015  Analyst Report Issued by ... Card Brands report showed that planet-wide, transactions at merchants on ... while the total number of credit, debit, and prepaid cards ... U.S. were victims of fraudulent card usage in 2012, and ...
(Date:1/22/2015)... , Jan. 22, 2015   EyeLock, Inc. , a market ... appointed Steve Gerber to the new role of ... responsible for leading development of mobile platforms and wearable solutions ... success and innovation in the semiconductor industry to his role ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... team led by Professor Tadashi ISA, Project Assistant ... Physiological Sciences, The National Institutes of Natural Sciences ... "the double viral vector transfection technique" which can ... combining two new kinds of gene transfer vectors. ...
... ,SALT LAKE CITY, June 14, 2012 In Israel,s Negev ... a toxic "mustard oil bomb" to make the spiny mouse ... the plant has turned a seed-eating rodent into a seed ... by Utah and Israeli scientists. "It,s fascinating that these ...
... International Olympic Committee (IOC) Medical and Scientific Department has ... Centre as an international leader in researching and preventing ... in the Faculty of Kinesiology, will be named one ... sites at a special reception to be held on ...
Cached Biology News:Manipulation of a specific neural circuit buried in complicated brain networks in primates 2Ptooey! 2Ptooey! 3Ptooey! 4IOC recognizes University of Calgary Sports Injury Research Prevention Centre 2
One-step, colorimetric, linear detection range 0.7 mg/dL to 300 mg/dL. Procedure: 10 min....
XBP1 Antibody...
... to histochemically detect specific ... pH in cultured cells ... specific marker is only ... (not found in presenescent/quiescent/immortal ...
Human/Mouse/Rat JNK Pan Specific Affinity Purified PAb...
Biology Products: